HDAC9 and neoplasm: Thus, HDACs may possibly be potential candidates for GSC-specific vulnerabilities, which can then be targeted with HDAC inhibitors, drugs that promote the acetylation of histones and open chromatin conformation at tumor suppressor gene loci and contribute to tumor suppression [10].